These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9193355)

  • 21. Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
    Sureda A; Petit J; Brunet S; Boqué C; Aventín A; Martino R; González JR; Amill B; Larriba I; Blanco A; Martín-Henao GA; Sierra J; Grañena A
    Bone Marrow Transplant; 1999 Dec; 24(12):1285-90. PubMed ID: 10627636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-alpha protects Philadelphia-negative progenitors from exhaustion in chronic myeloid leukemia patients with cytogenetic response.
    Frassoni F; Podestà M; Piaggio G; Rosti V; Pitto A; Soracco M; Figari O; Vassallo F; Fugazza G; Bergamaschi G; Bacigalupo A; Sessarego M; Cazzola M
    Hematol J; 2001; 2(1):26-32. PubMed ID: 11920230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy.
    Russo D; Martinelli G; Montefusco V; Amabile M; Rosti G; Marin L
    Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048
    [No Abstract]   [Full Text] [Related]  

  • 24. Very primitive hemopoietic cells (LTC-IC) are present in Philadelphia negative cytaphereses collected during early recovery after chemotherapy for chronic myeloid leukemia (CML).
    Podestà M; Piaggio G; Frassoni F; Sessarego M; Benvenuto F; Figari O; Pitto A; Vassallo F; Soracco M; Pollicardo N
    Bone Marrow Transplant; 1995 Oct; 16(4):549-55. PubMed ID: 8528171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon.
    McBride NC; Cavenagh JD; Newland AC; Lillington DM; Murrell C; Kelsey SM
    Bone Marrow Transplant; 2000 Dec; 26(11):1165-72. PubMed ID: 11149726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia].
    Hatsuse M; Okano A; Okamoto A; Shimura K; Takahashi R; Hirai H; Ashihara E; Inaba T; Fujita N; Shimazaki C; Nakagawa M
    Rinsho Ketsueki; 2000 Aug; 41(8):671-5. PubMed ID: 11020996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
    Carella AM; Podesta M; Frassoni F; Raffo MR; Pollicardo N; Pungolino E; Vimercati R; Sessarego M; Parodi C; Rabitti C
    Bone Marrow Transplant; 1993 Sep; 12(3):267-71. PubMed ID: 7694724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological control.
    Hughes TP; Grigg A; Szer J; Ho J; Ma D; Dale BM; Green RM; Norman JE; Sage RE; Herrmann R; Cannell P; Schwarer AP; Taylor K; Atkinson K; Arthur C
    Br J Haematol; 1997 Mar; 96(3):635-40. PubMed ID: 9054675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collection of Philadelphia-negative peripheral blood progenitor cells in unselected patients with chronic granulocytic leukaemia. Northern Regional Haematology Group.
    Lennard A; Storey N; Dickinson AM; Irving JA; Rowe D; Conn JS; Proctor SJ
    Leukemia; 1998 May; 12(5):746-52. PubMed ID: 9593273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of autotransplants in chronic myeloid leukaemia.
    Goldman JM; Deisseroth AB
    Bone Marrow Transplant; 1992; 10 Suppl 1():74-6. PubMed ID: 1355687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous exodus of high numbers of normal early progenitor cells (Ph-negative LTC-IC) in the peripheral blood of patients with chronic myeloid leukaemia at the beginning of the disease.
    Podestà M; Piaggio G; Sessarego M; Pitto A; Benvenuto F; Vassallo F; Fugazza G; Carella AM; Frassoni F
    Br J Haematol; 1997 Apr; 97(1):94-8. PubMed ID: 9136946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
    Sosman JA; Stiff P; Moss SM; Sorokin P; Martone B; Bayer R; van Besien K; Devine S; Stock W; Peace D; Chen Y; Long C; Gustin D; Viana M; Hoffman R
    J Clin Oncol; 2001 Feb; 19(3):634-44. PubMed ID: 11157013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
    Meng FY; Sun J; Liu QF; Xu D; Yang LJ; Song LL; Liu XL; Xu B; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobilisation of Ph-negative peripheral blood stem cells in CML with idarubicin and cytarabine.
    Chalmers EA; Franklin IM; Kelsey S; Clarke R; Sproul AM; Goldstone AH; Hepplestone A; Watson W; Sharp S; Tansey P
    Bone Marrow Transplant; 1994; 14 Suppl 3():S38-41. PubMed ID: 7697006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purging of peripheral blood stem cells yields BCR-ABL-negative autografts in patients with BCR-ABL-positive acute lymphoblastic leukemia.
    Martin H; Atta J; Zumpe P; Eder M; Elsner S; Rode C; Wassmann B; Bruecher J; Hoelzer D
    Exp Hematol; 1995 Dec; 23(14):1612-8. PubMed ID: 8542955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mobilization of cytogenetically 'normal' blood progenitors cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia.
    Carella AM; Pollicardo N; Pungolino E; Raffo MR; Podesta M; Ferrero R; Pierluigi D; Nati S; Naibo K; Congiu A
    Leuk Lymphoma; 1993 Apr; 9(6):477-83. PubMed ID: 8101754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia.
    Mehta J; Mijović A; Powles R; Pagliuca A; Singhal S; Czepulkowski B; Swansbury GJ; Treleaven J; Mufti GJ
    Bone Marrow Transplant; 1996 Jan; 17(1):25-9. PubMed ID: 8673050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autografting in chronic myeloid leukemia.
    Carella AM; Beltrami G; Corsetti MT
    Semin Hematol; 2003 Jan; 40(1):72-8. PubMed ID: 12563613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion.
    Lo Coco F; Mandelli F; Diverio D; Alimena G; De Fabritiis P; Meloni G; Cedrone M; Frontani M; Guerrasio A; Saglio G
    Bone Marrow Transplant; 1990 Oct; 6(4):253-8. PubMed ID: 2085700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.